Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. It blocks viral entry into host cells while preserving normal immunologic function. The Company is also investigating an intramuscular method of administration of Trogarzo. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy.


TSX:TH - Post by User

Bullboard Posts
Comment by longterm56on Jan 31, 2019 7:24pm
102 Views
Post# 29304360

RE:New Seeking Alpha Article on TH's NASH Chances

RE:New Seeking Alpha Article on TH's NASH ChancesSeriously???  Come on SPCEO, do you know how many articles a day are published by Seeking Alpha "gurus" ... attempting to get the crowd to buy what they just bought?  I put more value on your discussions with TH's management than the SA rag.  I think you're starting to stretch things a bit much. 

   -LT


SPCEO1 wrote: You have to pay a little to get access to it but you will likely find that payment to be worthwhile. The author runs somethign called the Liver Therapy Forum and is a MD/scientist. So, she gives a good scientific rationale for the liklihood of success of TH's NASH trial. Here is the link:

https://seekingalpha.com/research/24010943-first-genesis-consulting/5265847-theratechnologies-egrifta-intriguing-nash-play-likely-never-heard-imminent-catalyst



Bullboard Posts